-+ 0.00%
-+ 0.00%
-+ 0.00%

Biosenta says University of Calgary tests show Tri-Filler antimicrobial delivers 200-fold antibacterial gain

PUBT·07/21/2026 17:52:20
Listen to the news
Biosenta says University of Calgary tests show Tri-Filler antimicrobial delivers 200-fold antibacterial gain
  • Biosenta flagged independent University of Calgary lab results validating its Tri-Filler antimicrobial material, a step toward commercialization.
  • Testing showed more than a 200-fold improvement in antibacterial performance versus calcium hydroxide.
  • Early durability work indicated the material retained structural integrity and antibacterial properties after more than one year under elevated heat and humidity.
  • Commercialization plans include product validation, manufacturing scale-up, regulatory work, and industry partnerships.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosenta Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607211351NEWSFILECNPR____20260721_305978_1) on July 21, 2026, and is solely responsible for the information contained therein.